The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of 5-ALPHA reductase inhibitor use on prostate cancer risk at the time of urology referral.
 
James T Kearns
Travel, Accommodations, Expenses - AngioDynamics
 
Justin T. Matulay
No Relationships to Disclose
 
William E. Anderson
No Relationships to Disclose
 
Timothy C. Hetherington
No Relationships to Disclose
 
Claud Grigg
Consulting or Advisory Role - Pfizer/EMD Serono; Tempus
Travel, Accommodations, Expenses - Calithera Biosciences; Pfizer
 
Jason Zhu
Consulting or Advisory Role - Bayer; NGM Biopharmaceuticals
Travel, Accommodations, Expenses - UroToday
 
Kris E. Gaston
No Relationships to Disclose
 
Stephen Boyd Riggs
No Relationships to Disclose
 
Earle F Burgess
Stock and Other Ownership Interests - Arvinas; Becton Dickinson; Calithera Biosciences; Clovis Oncology; Corvus Pharmaceuticals; Exelixis; Gilead Sciences; Macrogenics; Medtronic; Merus NV
Honoraria - Bayer; Exelixis; Merck; Myovant Sciences
Consulting or Advisory Role - Johnson & Johnson
Speakers' Bureau - AstraZeneca
Research Funding - Astellas Pharma; Pfizer
 
Peter E Clark
Consulting or Advisory Role - Merck
(OPTIONAL) Uncompensated Relationships - Galil Medical